Validation of lymphatic mapping and sentinel node biopsy in patients with symptomatic breast cancer

Irish Journal of Medical Science

Volumn 175, Issue 2, 2006, Pages 59-62

  Cahill, R A ^a   Diamond, L ^a   Landers, R ^a   Walsh, D ^a   Watson, R G K ^a  

^a WATERFORD REGIONAL HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; RADIOISOTOPE; RHENIUM SULFIDE COLLOID TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MASTECTOMY; PRACTICE GUIDELINE; PREDICTION; SENTINEL LYMPH NODE BIOPSY; SYMPTOMATOLOGY; VALIDATION PROCESS;

EID: 33745890887     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03167952     Document Type: Article

References (14)

1. Guenther JM, Hansen NM, DiFronzo LA, et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 2003; 138: 52-56.
2. Nugent N, Hill ADK, Casey M, et al. Safety guidelines for radiolocalised sentinel node resection. Ir J Med Sci 170; 4: 236-238.
3. Beenkein SW, Urist MM, Zhang Y, et al. Axillary lymph node status, but not tumour size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer. Ann Surg 2003; 237 (5): 732-739.
4. Van der Wal BCH, Butzelaar MJM, van der Miej, Boermeester MA. Axillary lymph node ratio and total number of removed nodes: predictors of survival in stage I and II breast cancer. EJSO 2002; 28: 481-489.
5. Gervasoni JE, Taneja C, Chung MA, Cady B. Axillary dissection in the context of the biology of lymph node metastases. Am J Surg 2000; 180: 278-283.
6. De Kanter AY, van Eijck CH, van Geel AN et al. Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg 1999; 86 (11): 1459-1462.
7. Noguchi M. Sentinel node biopsy and breast cancer. Br J Surg 2002; 89: 21-34.
8. Blanchard DK, Donohue JH, Reynolds C, Grant CS. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2001; 138: 482-488.
9. Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenopathy for breast carcinoma. Cancer 2001; 92: 748-752.
10. Rutgers EJ, Nieweg OE. Finding lymph node metastases in invasive breast cancer: sampling or sentinel node procedure? EJSO 2002; 28: 569-570
11. Whitworth P, McMasters KM,Tafra L, Edwards MJ. State-of-the-art lymph node staging for the breast cancer in the year 2000. Am J Surg 2000; 180: 262-267.
12. Nieweg OE, Rutgers EJ, Jansen L, et al. Is lymphatic mapping in breast cancer adequate and safe. World J Surg 2001; 25: 780-788.
13. Karamlou T, Johnson NM, Chan B, Franzini D, Mahin D. Accuracy of intraoperative touch imprint cytologic analysis of sentinel lymph nodes in breast cancer. Am J Surg 2003 May; 185(5):425-428.
14. Mullenix PS, Carter PL, Martin MJ, et al. Predictive value of intraoperative touch preparation analysis of sentinel lymph nodes for axillary metastasis in breast cancer. Am J Surg 2003 May; 185(5):420-424